Abstract:
The possibility of reverting to the pre-antibiotic era is increasing. With dirty hospitals, poor prescribing practices by physicians, and poor patient adherence to correct antibiotic use, the threat was already real. But now an increase in the production of substandard medicines is probably accelerating antibiotic resistance. The UK government predicts that antimicrobial resistance (AMR) could cost society a fortune within decades. The threat of AMR is increasing because of poor-quality medications, and India is ground zero when it comes to most of the problems. Given that antibiotics are so cheap in India, antibiotic use is, in effect, a substitute for proper sanitation. It is not surprising that new versions of AMR are now emanating from India. My team’s research shows that at least 6 percent of thousands of antimicrobial medicines sampled from 19 emerging nations are substandard. In nearly every nation, poor-quality medicines made in India were found. Of the substandard products we procured, 40 percent were made by legal and government-protected Indian manufacturers. But India is not the only problem case, and a global effort is required to identify sloppy production and prevent these products from being used.
Antimicrobial resistance: How substandard medicines contribute
from AEI » Latest Content http://ift.tt/1HCC8LV
0 التعليقات:
Post a Comment